Skip to main content

ICD-10-PCS FY2026 (April) code changes

Historical release · ICD-10-PCS FY2026 (April) · Effective April 1, 2026 – September 30, 2026 ICD-10-PCS FY2027 is the release in force (effective October 1, 2026).

Part of FY2026 coding changes

Every recorded ICD-10-PCS code addition, deletion, description revision, billable-status change and tabular-instruction change for FY2026 (April), effective April 1, 2026.

These changes are based on recorded release data. MedCoder does not generate coding changes with AI.

Release
ICD-10-PCS FY2026 (April)
Effective
April 1, 2026
Code set period
2026-04-01 through 2026-09-30

FY2026 (April) at a glance

Explore the complete recorded change list →

Compare a code

Enter any ICD-10-PCS code to see what this release does to it: added, deleted, description revised, billable status changed, new child codes, or no change at all. The answer is a lookup against the recorded changes below — nothing is generated.

Deleted codes — what to report instead

These codes leave the code set on April 1, 2026. Where a successor was determined from the source files it is named below; where none was, that is stated rather than guessed.

No successor was determined for these codes.

FY2026 codeFY2026 descriptionFY2026 (April) statusEffective
30233AZTransfusion of Embryonic Stem Cells into Peripheral Vein, Percutaneous ApproachDeleted — not valid for submissionApril 1, 2026
30243AZTransfusion of Embryonic Stem Cells into Central Vein, Percutaneous ApproachDeleted — not valid for submissionApril 1, 2026

The full recorded change list

Every recorded change, grouped by what kind of change it is. Each entry shows the code's own description first; tabular instructions and relationship text are labeled separately beneath it.

Added to the code set (80)

  • 02HM3JZ — Insertion of Pacemaker Lead into Ventricular Septum, Percutaneous Approach
  • 02HM3KZ — Insertion of Defibrillator Lead into Ventricular Septum, Percutaneous Approach
  • 02HM3MZ — Insertion of Cardiac Lead into Ventricular Septum, Percutaneous Approach
  • 02HM3NZ — Insertion of Intracardiac Pacemaker into Ventricular Septum, Percutaneous Approach
  • 02HM3YZ — Insertion of Other Device into Ventricular Septum, Percutaneous Approach
  • 0DDU0ZZ — Extraction of Omentum, Open Approach
  • 0DDU4ZZ — Extraction of Omentum, Percutaneous Endoscopic Approach
  • 0DDV0ZZ — Extraction of Mesentery, Open Approach
  • 0DDV4ZZ — Extraction of Mesentery, Percutaneous Endoscopic Approach
  • 0F9480D — Drainage of Gallbladder with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transmural
  • 0F9480E — Drainage of Gallbladder with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transpapillary
  • 0F9580D — Drainage of Right Hepatic Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transmural
  • 0F9580E — Drainage of Right Hepatic Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transpapillary
  • 0F9680D — Drainage of Left Hepatic Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transmural
  • 0F9680E — Drainage of Left Hepatic Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transpapillary
  • 0F9780D — Drainage of Common Hepatic Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transmural
  • 0F9780E — Drainage of Common Hepatic Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transpapillary
  • 0F9880D — Drainage of Cystic Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transmural
  • 0F9880E — Drainage of Cystic Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transpapillary
  • 0F9980D — Drainage of Common Bile Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transmural
  • 0F9980E — Drainage of Common Bile Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transpapillary
  • 0F9C80D — Drainage of Ampulla of Vater with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transmural
  • 0F9C80E — Drainage of Ampulla of Vater with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transpapillary
  • 0F9D80D — Drainage of Pancreatic Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transmural
  • 0F9D80E — Drainage of Pancreatic Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transpapillary
  • 0F9F80D — Drainage of Accessory Pancreatic Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transmural
  • 0F9F80E — Drainage of Accessory Pancreatic Duct with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transpapillary
  • 0F9G80D — Drainage of Pancreas with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transmural
  • 0F9G80E — Drainage of Pancreas with Drainage Device, Via Natural or Artificial Opening Endoscopic, Transpapillary
  • 0TXB0Z6 — Transfer Bladder to Right Ureter, Open Approach
  • 0TXB0Z7 — Transfer Bladder to Left Ureter, Open Approach
  • 0TXB4Z6 — Transfer Bladder to Right Ureter, Percutaneous Endoscopic Approach
  • 0TXB4Z7 — Transfer Bladder to Left Ureter, Percutaneous Endoscopic Approach
  • 0VT00ZE — Resection of Prostate, Open Approach, Capsule Intact
  • 0VT04ZE — Resection of Prostate, Percutaneous Endoscopic Approach, Capsule Intact
  • 0VT07ZE — Resection of Prostate, Via Natural or Artificial Opening, Capsule Intact
  • 0VT08ZE — Resection of Prostate, Via Natural or Artificial Opening Endoscopic, Capsule Intact
  • 3E033AZ — Introduction of Embryonic Stem Cells into Peripheral Vein, Percutaneous Approach
  • 3E043AZ — Introduction of Embryonic Stem Cells into Central Vein, Percutaneous Approach
  • 4A0FXEJ — Measurement of Musculoskeletal Body Composition using Air Displacement Plethysmography, External Approach
  • 5A0221E — Assistance with Cardiac Output using Blood Flow Modulator, Continuous
  • F07DYD0 — Electrotherapeutic Treatment of Integumentary System - Head and Neck using Microcurrent Stimulation
  • F07EYD0 — Electrotherapeutic Treatment of Integumentary System - Thorax / Abdomen using Microcurrent Stimulation
  • F07FYD0 — Electrotherapeutic Treatment of Integumentary System - Upper Back / Upper Extremity using Microcurrent Stimulation
  • F07GYD0 — Electrotherapeutic Treatment of Integumentary System - Lower Back / Lower Extremity using Microcurrent Stimulation
  • F07HYD0 — Electrotherapeutic Treatment of Integumentary System - Whole Body using Microcurrent Stimulation
  • F08E5AZ — Wound Management Treatment of Integumentary System - Thorax / Abdomen using Negative Pressure Therapy
  • F08E5BZ — Wound Management Treatment of Integumentary System - Thorax / Abdomen using Physical Agents
  • F08E5CZ — Wound Management Treatment of Integumentary System - Thorax / Abdomen using Mechanical Equipment
  • F08E5DZ — Wound Management Treatment of Integumentary System - Thorax / Abdomen using Electrotherapeutic Equipment
  • F08E5EZ — Wound Management Treatment of Integumentary System - Thorax / Abdomen using Orthosis
  • F08E5FZ — Wound Management Treatment of Integumentary System - Thorax / Abdomen using Assistive, Adaptive, Supportive or Protective Equipment
  • F08E5UZ — Wound Management Treatment of Integumentary System - Thorax / Abdomen using Prosthesis
  • F08E5YZ — Wound Management Treatment of Integumentary System - Thorax / Abdomen using Other Equipment
  • F08E5ZZ — Wound Management Treatment of Integumentary System - Thorax / Abdomen
  • F08P5AZ — Wound Management Treatment of Musculoskeletal System - Thorax / Abdomen using Negative Pressure Therapy
  • F08P5BZ — Wound Management Treatment of Musculoskeletal System - Thorax / Abdomen using Physical Agents
  • F08P5CZ — Wound Management Treatment of Musculoskeletal System - Thorax / Abdomen using Mechanical Equipment
  • F08P5DZ — Wound Management Treatment of Musculoskeletal System - Thorax / Abdomen using Electrotherapeutic Equipment
  • F08P5EZ — Wound Management Treatment of Musculoskeletal System - Thorax / Abdomen using Orthosis
  • F08P5FZ — Wound Management Treatment of Musculoskeletal System - Thorax / Abdomen using Assistive, Adaptive, Supportive or Protective Equipment
  • F08P5UZ — Wound Management Treatment of Musculoskeletal System - Thorax / Abdomen using Prosthesis
  • F08P5YZ — Wound Management Treatment of Musculoskeletal System - Thorax / Abdomen using Other Equipment
  • F08P5ZZ — Wound Management Treatment of Musculoskeletal System - Thorax / Abdomen
  • X2723CB — Dilation of Inferior Vena Cava and Iliocaval Confluence with Open-structure Polymer Lattice Intraluminal Device, Percutaneous Approach, New Technology Group 11
  • X2HM3GB — Insertion of Lumenless Small-diameter Defibrillator Lead into Ventricular Septum, Percutaneous Approach, New Technology Group 11
  • X2HV3GB — Insertion of Lumenless Small-diameter Defibrillator Lead into Right Ventricle, Percutaneous Approach, New Technology Group 11
  • X2K00FB — Bypass Inferior Vena Cava using Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery, Open Approach, New Technology Group 11
  • X2KG0FB — Bypass Hepatic Vein using Autologous Cell Seeded Tissue Engineered Resorbable Scaffold to Pulmonary Artery, Open Approach, New Technology Group 11
  • X9HD01B — Insertion of Temporary Infusion Device into Right Inner Ear, Open Approach, New Technology Group 11
  • X9HE01B — Insertion of Temporary Infusion Device into Left Inner Ear, Open Approach, New Technology Group 11
  • X9HF01B — Insertion of Temporary Infusion Device into Bilateral Inner Ear, Open Approach, New Technology Group 11
  • XU7G71B — Dilation of Vagina with Temporary Electromechanical Intraluminal Device, Via Natural or Artificial Opening, New Technology Group 11
  • XW0330B — Introduction of Alpha1-proteinase Inhibitor into Peripheral Vein, Percutaneous Approach, New Technology Group 11
  • XW0331B — Introduction of Anitocabtagene Autoleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 11
  • XW0430B — Introduction of Alpha1-proteinase Inhibitor into Central Vein, Percutaneous Approach, New Technology Group 11
  • XW0431B — Introduction of Anitocabtagene Autoleucel Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 11
  • XW0534B — Introduction of Somatic Stem Cells into Peripheral Artery, Percutaneous Approach, New Technology Group 11
  • XW0632B — Introduction of CPI-601 Enzyme Replacement Therapy into Cerebral Ventricle, Percutaneous Approach, New Technology Group 11
  • XW0E33B — Introduction of DB-OTO via Intracochlear Infusion into Ear(s), Percutaneous Approach, New Technology Group 11

Removed from the code set (2)

  • 30233AZ — Transfusion of Embryonic Stem Cells into Peripheral Vein, Percutaneous Approach
  • 30243AZ — Transfusion of Embryonic Stem Cells into Central Vein, Percutaneous Approach

Sources

Official source data

Publisher
Centers for Medicare & Medicaid Services (CMS) and the National Center for Health Statistics (CDC/NCHS)
Release
ICD-10-PCS FY2026 (April)
File checksum (SHA-256)
5c4f2fdb4dcc184c15c3b2b2003020c9b48c148d3489e4efb3486a72b3bfebfb
Data type
Public domain code descriptions and tabular instructions. No licensed content.

MedCoder-derived analysis

Change detection
Every addition, deletion, description revision, billable-status change and tabular-instruction change on this page is computed by diffing the two code-description files above, line by line.
Editorial analysis
The grouping of changes into themes, the successor determinations and the coder-impact notes are written by MedCoder against those files. They are not CMS statements.
Independence
MedCoder is an independent coding reference built on public federal data. It is not affiliated with, endorsed by or certified by CMS, and it is not an official CMS coding tool.

Continue

All releases in the Change Ledger

Cite this page

Reference this page in a research guide, syllabus or article. The release is included because code content changes each year.

MedCoder.ai. "ICD-10-PCS FY2026 (April) code changes." ICD-10-PCS FY2026 (April). https://medcoder.ai/updates/icd10pcs/icd10pcs-fy2026